vai alle Pubblicazioni
Pubblicazioni antecedenti il 2004
Paper with IF published before 2004
· Cicero AFG,
Bandieri E, Arletti R. Orally administered Panax notoginseng
influences rat spontaneous behaviour. Journal of Ethnopharmacology
(J Ethnopharmacol) 2000; 73: 387-391.
· Cicero AFG,
Braiato A, D'Addato S, Sangiorgi Z, Gaddi A. A suggestion for
Familial Hypercholesterolemia (FH) heterozygosity clinical
diagnosis based on an epidemiological observation in a large
Italian population. International Journal of Cardiology (Int J
Cardiol) 2000; 74: 5-11.
· Gaddi A,
Berto P, Mussoni C, Cicero AFG, D'Addato S, Cantagalli F.
Antihyperlipidaemic drugs: the results of a Drug Utilisation Review
(DUR) research in the Bologna area. Clinical Drug Investigation
(Clin Drug Invest) 2000; 19(6): 457-464.
· CiceroAFG,
Bandieri E, Arletti R. Lepidium meyenii Walp. improves sexual
behaviour in male rats independently from its action on spontaneous
locomotor activity. Journal of Ethnopharmacology (J Ethnopharmacol)
2001; 75(2-3): 225-229.
· Cicero AFG,
Gaddi A. Rice Bran oil and g-oryzanol in the treatment of
hyperlipoproteinemias and other conditions. Phytotherapy Research
(Phytother Res) 2001; 15(4): 277-289. [Review]
· Cicero AFG,
Martini C, Fiorito A, Gaddi A. Case Problem: Dietary treatment for
children with hyperlipidemia. Journal of the American Dietetic
Association (J Am Diet Ass) 2001; 101: 693-696.
· Gaddi A,
Cicero AFG, Dormi A, Pasquarelli V, D'Addato S. The realisation of
a project aimed at reducing the plasmatic lipid level in a large
Italian rural population improves the mean calcium daily intake:
the Brisighella Study (BS). European Journal of Clinical Nutrition
(Eur J Clin Nutr) 2001; 55(2): 97-106.
· Pini LA,
Cicero AFG, Sandrini M. Long-term follow-up of patients treated for
chronic headache with analgesics overuse. Cephalalgia 2001; 21:
878-883.
· Pini LA,
Cicero AFG. Triptans: the experience of a clinical pharmacologist
in clinical practice. Journal of Headache and Pain (J Headache
Pain) 2001; 2(S1): 103-106.
·
Borghi C, Dormi A, Ambrosioni E, Gaddi A; On behalf of the
Brisighella Heart Study working party (in which Cicero AFG).
Relative role of systolic, diastolic and pulse pressure as risk
factors for cardiovascular events in the Brisighella Heart Study.
Journal of Hypertension (J Hypertens) 2002; 20(9):1737-1742.
· Cicero AFG,
Fiorito A, Panourgia MP, Sangiorgi Z, Gaddi A. Effects of a new
soy/b-sitosterol supplement on plasma lipids in moderately
hypercholesterolemic subjects. Journal of the American Dietetic
Association (J Am Diet Ass) 2002; 102(12): 1807-1811.
· Cicero AFG,
Piacente S, Plaza A, Sala E, Arletti R, Pizza C. Hexanic Maca
extract improves rat sexual performance more effectively than
methanolic and chloroformic Maca extracts. Andrologia 2002; 34(3):
177-179.
· Gaddi A,
Cicero AFG, Poli A, Nascetti S, Inzitari D on behalf of the Italian
Study Group for the study of Dysmetabolic Diseases and
Atherosclerosis. Cerebrovascular disease in Italy and Europe: it is
necessary to prevent a "pandemia". Journal of Cardiovascular Risk
(J Cardiovasc Risk) 2002; 9: 1-3. [Editorial]
· Pini LA,
Cicero AFG, Sandrini M. Long-term follow-up of patients treated for
chronic headache with analgesics overuse [Author's reply].
Cephalalgia 2002; 22: 327-328.
· Borghi
C, Dormi A, L'Italien G, Lapuerta P, Franklin SS, Collatina S,
Gaddi A on behalf of the Brisighella Heart Study working party (in
which Cicero AFG). The relationship between systolic blood pressure
and cardiovascular risk--results of the Brisighella Heart Study.
Journal of Clinical Hypertension (J Clin Hypertens) 2003; 5(1):
47-52.
· Cicero AFG, Derosa
G, Gaddi A. Homocysteine and cardiovascular risk. Journal of
Headache and Pain (J Headache Pain) 2003; 4(3): 171-172.
[Letter]
· Cicero AFG,
Fiorito A, Rontini T, Nascetti S, Sangiorgi Z, Dormi A, Gaddi A.
Dietary habits did not influence plasma antibodies against oxidized
LDL level in a wide sample of healthy subjects: the Brisighella
Heart Study. Vaccine 2003; 21(S 2):S35-S37.
· Cicero AFG,
Forghieri M, Arletti R. Hypercholesterolemia underdiagnosis and
undertreatment in psychiatric patients in Italy. European Journal
of Epidemiology (Eur J Epidemiol) 2003; 18: 373-374.
· Cicero AFG,
Panourgia MP, Linarello S, D'Addato S, Sangiorgi Z, Gaddi A. Serum
lipoprotein(a) levels in a large sample of subjects affected by
familial combined hyperlipoproteinemia (FCH) and in general
population. Journal of Cardiovascular Risk (J Cardiovasc Risk)
2003; 10(2): 149-151.
· Cicero AFG,
Panourgia MP, Nascetti S, Sangiorgi Z, Gaddi A. Asymptomatic
massive hypertriglyceridemia in an octogenarian. Medicine
Principles and Practice (Med Princ Pract) 2003; 12: 51-53.
· Cicero AFG,
Vitale G, Savino G, Arletti R. Panax notoginseng (Burk.) effects on
fibrinogen and lipid plasma level in rats fed on a high-fat diet.
Phytotherapy Research (Phytother Res) 2003; 17(2): 174-178.
· Derosa G,
Cicero AFG, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. A
randomized, double-blind, controlled parallel-group comparison of
perindopril and candesartan in hypertensive patients with type 2
diabetes mellitus. Clinical Therapeutics (Clin Ther) 2003; 25(7):
2006-2021.
· Derosa G,
Cicero AFG, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. The
effect of L-carnitine on plasma lipoprotein (a) levels in
hypercholesterolemic patients with type 2 diabetes mellitus.
Clinical Therapeutics (Clin Ther) 2003; 25(5): 1429-1439.
· Derosa G,
Cicero AFG, Mugellini A, Ciccarelli L, Fogari R. Perindopril and
Candesartan comparative efficacy and safety in type 2 diabetic
hypertensive patients. Journal of Human Hypertension (J Hum Hypert)
2003; 17(6): 433-435.
· Gaddi A,
Cicero AFG, Nascetti S, Poli A, Inzitari D on behalf of the Italian
Study Group for the study of Dysmetabolic Diseases and
Atherosclerosis. Cerebrovascular disease in Italy and Europe: it is
necessary to prevent a "pandemia". Gerontology 2003; 49(2): 69-79.
[Review]
· Gaddi A, Poli
A, Cicero AFG, Inzitari D on behalf of the Italian Study Group for
the study of Dysmetabolic Diseases and Atherosclerosis. It is
necessary to prevent a cerebrovascular "pandemia". Cerebrovascular
Disease (Cerebrovasc Dis) 2003; 15(1-2): 152-153. [Letter]
· Sternieri E,
Ferrari A, Cicero AFG. Clinical considerations preliminary to the
application of the Italian Society for the Study of Headache
Guidelines regarding the Migraine Prophylactic Treatment. Journal
of Headache and Pain (J Headache Pain) 2003; 4(1): 14-17.
[Editorial]
· Borghi C,
Dormi A, D'Addato S, Gaddi A, Ambrosioni E on behalf of the
Brisighella Heart Study Working Party (in which Cicero AFG). Trends
in blood pressure control and antihypertensive treatment in
clinical practice: the Brisighella Heart Study. Journal of
Hypertension (J Hypert) 2004; 22: 1707–1716.
· Borghi C,
Dormi A, Veronesi M, Sangiorgi Z, Gaddi A on behalf of the
Brisighella Heart Study Working Party (in which Cicero AFG).
Association between different lipid-lowering treatment strategies
and blood pressure control in the Brisighella Heart Study. American
Heart Journal (Am Heart J) 2004; 148: 285–292.
· Cicero AFG,
Derosa G, Arletti R. Effect of oral chronic isoflavones
supplementation on male rat sexual performances and sexual hormone
plasma levels. Phytotherapy Research (Phytother Res) 2004; 18:
849-852.
· Cicero AFG,
Derosa G, Brillante R, Mirembe S, Nascetti S, Gaddi A. Effects of
Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly
quality of life: a randomized clinical trial. Archives of
Geriatrics and Gerontology (Arch Geriatr Gerontol) 2004; 38S:
69-73.
· Cicero AFG,
Derosa G, Gaddi A. What herbalists suggest to our diabetic patients
in order to improve their glycaemic control? Evaluation of
scientific evidences and potential risks. Acta Diabetologica (Acta
Diabetol) 2004; 41(3): 91-98.
· Cicero AFG,
Minardi M, Mirembe S, Pedro E, Gaddi A. Effects of a new low dose
soy protein/b-sitosterol association on plasma lipid levels and
oxidation. European Journal of Nutrition (Eur J Nutr) 2004; 43(5):
319-322.
· Derosa G,
Cicero AFG, Bertone G, Piccinni MN, Fogari E, Ciccarelli L, Fogari
R. Comparison of the effects of telmisartan and nifedipine
gastrointestinal therapeutic system on blood pressure control,
glucose metabolism, and the lipid profile in patients with type 2
diabetes mellitus and mild hypertension: a 12-month, randomized,
double-blind study. Clinical Therapeutics (Clin Ther) 2004; 26(8):
1228-1236.
· Derosa G,
Cicero AFG, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli
L, Piccinini MN. Metabolic effects of Pioglitazone and
Rosiglitazone in patients with diabetes and metabolic syndrome
treated with Glimepiride: a twelve-month, multicenter,
double-blind, randomized, controlled, parallel-group trial.
Clinical Therapeutics (Clin Ther) 2004; 26(5): 744-754.
· Derosa G,
Cicero AFG, Murdolo G, Ciccarelli L, Fogari R. Comparison of
metabolic effects of orlistat and sibutramine treatment in type 2
diabetic obese patients. Diabetes Nutrition and Metabolism (Diab
Nutr Metab) 2004; 17(4): 222-230.
·
Derosa G,
Cicero AFG,
Bertone G,
Piccinni MN,
Ciccarelli L,
Roggeri DE. Comparison of fluvastatin + fenofibrate combination
therapy and fluvastatin monotherapy in the treatment of combined
hyperlipidemia, type 2 diabetes mellitus, and coronary heart
disease: a 12-month, randomized, double-blind, controlled trial.
Clinical Therapeutics (Clin Ther) 2004; 26(10): 1599-607.
· Ferrari A,
Pasciullo G, Savino G, Cicero AFG, Ottani A, Bertolini A, Sternieri
E. Headache treatment before and after the consultation of a
specialized centre: a pharmacoepidemiology study. Cephalalgia 2004;
24(5): 356-362.
· Gaddi A,
Cicero AFG, Pedro E. Clinical perspectives of anti-inflammatory
therapy in the elderly: the Lox-/Cox- inhibition concept. Archives
of Geriatrics and Gerontology (Arch Geriatr Gerontol) 2004; 38(3):
201-212. [Review]